Strategies to tackle SARS-CoV-2 Mu, a newly classified variant of interest likely to resist currently available COVID-19 vaccines현재 사용 가능한 COVID-19 백신에 저항할 가능성이 있는 새로 분류된 관심 변종인 SARS-CoV-2 Mu에 대처하기 위한 전략Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2022.2027197 PMC 바로가기 [Article Type] Article
The efficacy and effectiveness of the COVID-19 vaccines in reducing infection, severity, hospitalization, and mortality: a systematic review감염, 중증도, 입원 및 사망률 감소에 대한 COVID-19 백신의 효능 및 효과: 체계적인 검토Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2022.2027160 PMC 바로가기 [Article Type] Article
A statistical look at the COVID-19 vaccine development and vaccine policiesArticle Published on 2022-12-052023-07-11 Journal: Frontiers in Public Health [Category] [DOI] 10.3389/fpubh.2022.1048062 PMC 바로가기
A replication-competent smallpox vaccine LC16m8Δ-based COVID-19 vaccineArticle Published on 2022-12-012022-11-15 Journal: Emerging Microbes & Infections [Category] [DOI] 10.1080/22221751.2022.2122580 PMC 바로가기
A SARS-CoV-2 vaccine based on conjugation of SARS-CoV-2 RBD with IC28 peptide and mannanArticle Published on 2022-12-012022-11-15 Journal: International journal of biological macromolecules [Category] [DOI] 10.1016/j.ijbiomac.2022.09.180 PMC 바로가기
A Qualitative Study of COVID-19 Vaccine Decision Making Among Urban Native AmericansResearch article Published on 2022-12-012022-10-05 Journal: Vaccine: X [Category] [DOI] 10.1016/j.jvacx.2022.100212 [Article Type] Research article
Using a “systems therapeutic for physiological renormalization” approach to vaccine development. Covid-19 as an example백신 개발에 "생리학적 재정규화를 위한 시스템 치료" 접근 방식을 사용합니다. 코로나19를 예로 들어Article Published on 2022-11-302022-09-11 Journal: Human vaccines & immunotherapeutics [Category] [DOI] 10.1080/21645515.2022.2043105 PMC 바로가기 [Article Type] Article
Antigenic mapping reveals sites of vulnerability on α-HCoV spike proteinArticle Published on 2022-11-042022-11-15 Journal: Communications Biology [Category] [DOI] 10.1038/s42003-022-04160-8 PMC 바로가기
Modular nanoarray vaccine for SARS-CoV-2Article Published on 2022-11-012022-11-15 Journal: Nanomedicine : nanotechnology, biology, and medici [Category] [DOI] 10.1016/j.nano.2022.102604 PMC 바로가기
Towards the development of an epitope-focused vaccine for SARS-CoV-2Article Published on 2022-10-262022-11-15 Journal: Vaccine [Category] [DOI] 10.1016/j.vaccine.2022.09.059 PMC 바로가기